Division of Nephrology

David Russell

MD, FRCPC

Chief of Medicine, St. Joseph's Healthcare

Director, Renal Transplant Program

Associate Professor, Division of Nephrology, Department of Medicine

 

 

 

Education and Training

  • FRCPC Nephrology (McMaster) 1989
  • Diploma in Critical Care Medicine 1987
  • FRCPC Internal Medicine (McMaster) 1986
  • MD (McMaster) 1982

Administrative Responsibilities

  • Chief of Medicine, St. Joseph's Healthcare
  • Director, Renal Transplant Program

Clinical Interests

  • Kidney transplantation
  • Cardiac disease in patients with chronic kidney disease

Research Interests

  • Non-invasive cardiac testing for wait-listed transplant patients
  • Cardiovascular disease after renal transplantation
  • Clinical trials in immunosuppressive drugs

Selected Publications

  1. JS Saltzman, A Boucher, S Busque, PF Halloran, DN Landsberg, V McAlistair, D Russell, A Shoker, J Shapiro et al., A prospective 3 yr evaluation of tacrolimus-based immunosuppressive therapy in Immunologically high risk renal allograft recipients., Clin Transplant 2005; 19: 26-32.
  2. C Rabbat, D Treleaven, D Russell, D Ludwin, D Cook., Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney-pancreas transplantation: A meta-analysis., J Am Soc Nephrol 14:431-439, 2003.
  3. E Cole, D Landsberg, D Russell, J Zaltzman, B Kiberd, C Caravaggio, A Vasquez, P Halloran., A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients., Transplantation. Transplantation 2001;72(5):845-50.
  4. CG Rabbat, KE Thorpe, JD Russell, DN Churchill., Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada., J Am Soc Nephrol 2000;11(5):917-22.